Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.
(aztreonam)
3,821 results
  • Multidrug-Resistant ESBL-Producing E. coli in Clinical Samples from the UK. [Journal Article]
    Antibiotics (Basel). 2023 Jan 13; 12(1)Ibrahim DR, Dodd CER, … Hobman JL
  • Globally, cephalosporin therapy failure is a serious problem for infection control. One causative agent of cephalosporin-resistant infections is multidrug-resistant (MDR) E. coli producing extended-spectrum β-lactamases (ESBLs) and/or plasmid-encoded AmpC (pAmpC) β-lactamases. We evaluated the occurrence of ESBL/pAmpC genetic determinants in phenotypically MDR E. coli isolated from clinical sampl…
  • Characterization of Acinetobacter baumannii Isolated from Raw Milk. [Journal Article]
    Biology (Basel). 2022 Dec 18; 11(12)Mohamed HMA, Abd-Elhafeez HH, … El-Zamkan MA
  • Acinetobacter baumannii (A. baumannii) is an opportunistic pathogen associated with nosocomial infections. In this study, 100 raw milk samples were collected from Qena, Egypt, and subjected to conventional and molecular assays to determine the presence of A. baumannii and investigate their antimicrobial resistance and biofilm formation. Our findings revealed that, among the 100 samples, Acinetoba…
  • Current and Emerging Treatment Options for Multidrug Resistant Escherichia coli Urosepsis: A Review. [Review]
    Antibiotics (Basel). 2022 Dec 15; 11(12)Walker MM, Roberts JA, … Sime FB
  • Escherichia coli is a versatile commensal and pathogenic member of the human microflora. As the primary causative pathogen in urosepsis, E. coli places an immense burden on healthcare systems worldwide. To further exacerbate the issue, multi drug resistance (MDR) has spread rapidly through E. coli populations, making infections more troublesome and costlier to treat. This paper aimed to review th…
New Search Next